Document Detail

Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study.
MedLine Citation:
PMID:  21477998     Owner:  NLM     Status:  Publisher    
The objective of this study was to compare coronary heart disease (CHD) risk and metabolic syndrome (MS) prevalence in patients with deficit (DS) and non-deficit schizophrenia treated with antipsychotics. A total of 1452 antipsychotic-treated outpatients meeting criteria for schizophrenia, schizophreniform or schizoaffective disorder were included in this cross-sectional multicentre study. CHD risk was assessed by SCORE (10-year cardiovascular death) risk score, and metabolic syndrome was assessed according to NCEP-ATP III criteria. A total of 1452 patients (863 men, 60.9%), 40.7±12.2years (mean±SD) were included. DS was found in 404 patients (35.1%). Patients with DS were older, more frequently male and obese, more likely to be receiving sickness benefits, and had longer illness duration and fewer previous hospitalisations. Furthermore, DS patients had higher negative PANSS scores (56.3% vs. 40.6% of patients with PANSS-N>21). High/very high risk of fatal CHD according to SCORE function (≥3%) was significantly higher in DS [11.8% (95% CI: 8.8-15.5) vs. 6.0% (95% CI: 4.4-8.1), (p<0.05)]. Schizophrenia spectrum patients with DS were more obese and had a higher CHD risk than non-deficit patients.
Celso Arango; Julio Bobes; Brian Kirkpatrick; Margarida Garcia-Garcia; Javier Rejas
Related Documents :
12357088 - The low normothermia concept--maintaining a core body temperature between 36 and 37 deg...
1209788 - Stroke before fifty. experiences from a five-year study.
6736978 - Predicting the outcome of acute stroke: a prognostic score.
9973658 - Protein s deficiency, activated protein c resistance and sticky platelet syndrome in a ...
2787888 - Immunological abnormalities in the chronic fatigue syndrome.
2045928 - In vivo spect quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-6
Journal Detail:
Title:  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology     Volume:  -     ISSN:  1873-7862     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111390     Medline TA:  Eur Neuropsychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Psychiatry Department, Hospital General Universitario Gregorio Marañón and Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrinsic aging- and photoaging-dependent level changes of glycosaminoglycans and their correlation ...
Next Document:  Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug ana...